CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed on August 6, 2018, by CollPlant Holdings Ltd., a foreign private issuer based in Israel. The filing discloses a material corporate event regarding a private placement of equity completed in late July 2018.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The only specific financial metric disclosed relates to the capital raise:
- Capital Raised: NIS 4,561,250 (approximately $1.25 million USD).
- Shares Issued: 11,125,000 ordinary shares.
- Transaction Date: Closed on July 31, 2018.
Material Changes
The primary material change is the increase in outstanding share count and equity capital resulting from the private placement. On July 26, 2018, the Company entered into a securities purchase agreement with Ami Sagi, which was finalized on July 31, 2018. This transaction represents a dilution of existing shareholders but provides immediate liquidity to the Company.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the transaction terms. No unusual items or contingencies were reported in this specific document.
Investor Verification Checklist
- Verify the exact exchange rate used to convert NIS 4,561,250 to USD to confirm the $1.25 million valuation.
- Confirm the post-transaction total share count to assess the dilution impact on existing shareholders.
- Review the full text of the Purchase Agreement for any restrictive covenants or rights granted to Ami Sagi.
- Check subsequent filings for the intended use of the raised capital.